диссертации / 73
.pdf297.Deeken CR, Abdo MS, Frisella MM, Matthews BD. Physicomechanical evaluation of absorbable and nonabsorbable barrier composite meshes for laparoscopic ventral hernia repair. Surg Endosc 2011; 25 (5): 1541-1552.
298.Gruber-Blum S, Petter-Puchner AH, Brand J et al. Comparison of three separate antiadhesive barriers for intraperitoneal onlay mesh hernia repair in an experimental model. Br J Surg 2010.
299.Лядов В.К., Шрайнер И.В., Головинский С.В. и соавт. Влияние коллагенового покрытия на выраженность брюшных сращений с полипропиленовой сеткой -
экспериментальное исследование на модели кролика Вопросы реконструктивной и
пластической хирургии 2007; (3-4): 73-75.
300.Loury JN, Chevrel JP. [Treatment of ventral hernias. Simultaneous use of polyglactin 910 and dacron mesh]. Presse Med 1983; 12 (34): 2116.
301.de Vries Reilingh TS, van Goor H, Koppe MJ et al. Interposition of polyglactin mesh does not prevent adhesion formation between viscera and polypropylene mesh. J Surg Res 2007; 140 (1): 27-30.
302.Conze J, Junge K, Klinge U et al. Intraabdominal adhesion formation of polypropylene mesh. Influence of coverage of omentum and polyglactin. Surg Endosc 2005; 19 (6): 798-803.
303.Bellon JM, Rodriguez M, Garcia-Honduvilla N et al. Peritoneal effects of prosthetic meshes used to repair abdominal wall defects: monitoring adhesions by sequential laparoscopy. J Laparoendosc Adv Surg Tech A 2007; 17 (2): 160-166.
304.Burger JW, Halm JA, Wijsmuller AR et al. Evaluation of new prosthetic meshes for ventral hernia repair. Surg Endosc 2006; 20 (8): 1320-1325.
305.Emans PJ, Schreinemacher MH, Gijbels MJ et al. Polypropylene meshes to prevent abdominal herniation. Can stable coatings prevent adhesions in the long term? Ann Biomed Eng 2009; 37 (2): 410-418.
306.Jacob BP, Hogle NJ, Durak E et al. Tissue ingrowth and bowel adhesion formation in an animal comparative study: polypropylene versus Proceed versus Parietex Composite. Surg Endosc 2007; 21 (4): 629-633.
281
307.Judge TW, Parker DM, Dinsmore RC. Abdominal wall hernia repair: a comparison of sepramesh and parietex composite mesh in a rabbit hernia model. J Am Coll Surg 2007;
204(2): 276-281.
308.Schreinemacher MH, Emans PJ, Gijbels MJ et al. Degradation of mesh coatings and intraperitoneal adhesion formation in an experimental model. Br J Surg 2009; 96 (3): 305-
309.van 't Riet M, de Vos van Steenwijk PJ, Bonthuis F et al. Prevention of adhesion to prosthetic mesh: comparison of different barriers using an incisional hernia model. Ann Surg 2003; 237 (1): 123-128.
310.Vrijland WW, Bonthuis F, Steyerberg EW et al. Peritoneal adhesions to prosthetic materials: choice of mesh for incisional hernia repair. Surg Endosc 2000; 14 (10): 960-963.
311.Chelala E, Debardemaeker Y, Elias B et al. Eighty-five redo surgeries after 733 laparoscopic treatments for ventral and incisional hernia: adhesion and recurrence analysis. Hernia 2010; 14 (2): 123-129.
312.Jenkins ED, Yom V, Melman L et al. Prospective evaluation of adhesion characteristics to intraperitoneal mesh and adhesiolysis-related complications during laparoscopic re-exploration after prior ventral hernia repair. Surg Endosc 2010; 24 (12): 3002-3007.
313.Wassenaar EB, Schoenmaeckers EJ, Raymakers JT, Rakic S. Subsequent abdominal surgery after laparoscopic ventral and incisional hernia repair with an expanded polytetrafluoroethylene mesh: a single institution experience with 72 reoperations. Hernia 2010; 14 (2): 137-142.
314.Zinther NB, Zeuten A, Marinovskij E et al. Functional cine MRI and transabdominal ultrasonography for the assessment of adhesions to implanted synthetic mesh 5-7 years after laparoscopic ventral hernia repair. Hernia 2010; 14 (5): 499-504.
315.Junge K, Rosch R, Klinge U et al. Gentamicin supplementation of polyvinylidenfluoride mesh materials for infection prophylaxis. Biomaterials 2005; 26 (7): 787-793.
316.Лютова И.Г., Анучина Н.М., Бакулева Н.П. и соавт. Антимикробные свойства биопротезов с покрытием наноструктурированным низкомолекулярным хитозаном
282
Бюллетень НЦССХ ИМ. А.Н. БАКУЛЕВА РАМН Сердечно-сосудистые
заболевания 2013; 14 (1): 52-57.
317.Иванов И.С., Иванов С.В., Должиков А.А. и соавт. Влияние эмбриональных фибробластов на динамику раневого процесса при эндопротезировании брюшной стенки (экспериментальное исследование) Курский научно-практический вестник Человек и его здоровье 2009; (4): 61-68.
318.Иванов С.В., Иванов И.С., Должиков А.А. и соавт. Морфология тканей при использовании протезов из полипропилена и политетрафторэтилена Анналы хирургии 2009; (3): 59-63.
319.Franz MG, Kuhn MA, Nguyen K et al. Transforming growth factor beta(2) lowers the incidence of incisional hernias. J Surg Res 2001; 97 (2): 109-116.
320.Shastri VP. Non-degradable biocompatible polymers in medicine: past, present and future. Curr Pharm Biotechnol 2003; 4 (5): 331-337.
321.Shen M, Horbett TA. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 2001; 57 (3): 336-345.
322.Wisniewski N, Reichert M. Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces 2000; 18 (3-4): 197-219.
323.de Vos P, Hoogmoed CG, Busscher HJ. Chemistry and biocompatibility of alginatePLL capsules for immunoprotection of mammalian cells. J Biomed Mater Res 2002; 60 (2): 252-259.
324.de Vos P, van Hoogmoed CG, de Haan BJ, Busscher HJ. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J Biomed Mater Res 2002; 62 (3): 430-437.
325.Vercruysse KP, Prestwich GD. Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 1998; 15 (5): 513-555.
326.Borchard G, Junginger HE. Modern drug delivery applications of chitosan. Adv Drug Deliv Rev 2001; 52 (2): 103.
327.Uchegbu IF, Schatzlein AG, Tetley L et al. Polymeric chitosan-based vesicles for drug delivery. J Pharm Pharmacol 1998; 50 (5): 453-458.
283
328. Чернооков А.И., Хоробрых Т.В., Наумов Б.А. и соавт. Грыжесечение с протезирующей пластикой легкими сетками и обработкой фибриновым клеем в экстренной хирургии послеоперационных вентральных грыж Анналы хирургии
2009; (4): 49-54.
329.Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-
2.Adv Drug Deliv Rev 2003; 55 (12): 1613-1629.
330.Sano A, Hojo T, Maeda M, Fujioka K. Protein release from collagen matrices. Adv Drug Deliv Rev 1998; 31 (3): 247-266.
331.Парфенов И.П., Должиков А.А., Мишустин А.М. и соавт. Пути профилактики послеоперационных осложнений в хирургии грыж передней брюшной стенки Научные ведомости Белгородского государственного университета. Серия:
Медицина. Фармация 2011; 14 (10): 93-97.
332.Draye JP, Delaey B, Van de Voorde A et al. In vitro release characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 1998; 19 (1-3): 99-107.
333.Draye JP, Delaey B, Van de Voorde A et al. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 1998; 19 (18): 16771687.
334.Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17 (2): 93-102.
335.Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS. Applications of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 1995; 12 (3): 475-
336.Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28 (1): 5-24.
337.Espadas-Torre C, Meyerhoff ME. Thrombogenic properties of untreated and poly(ethylene oxide)-modified polymeric matrices useful for preparing intraarterial ionselective electrodes. Anal Chem 1995; 67 (18): 3108-3114.
284
338.Maruoka S, Matsuura T, Kawasaki K et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 2006; 31 (7-8): 599-606.
339.Paradossi G, Cavalieri F, Chiessi E et al. Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications. J Mater Sci Mater Med 2003; 14 (8): 687-691.
340.Schug-Pass C, Sommerer F, Tannapfel A et al. The use of composite meshes in laparoscopic repair of abdominal wall hernias: are there differences in biocompatibily?: experimental results obtained in a laparoscopic porcine model. Surg Endosc 2009; 23 (3): 487-495.
341.Voskerician G, Jin J, White MF et al. Effect of biomaterial design criteria on the performance of surgical meshes for abdominal hernia repair: a pre-clinical evaluation in a chronic rat model. J Mater Sci Mater Med 2010; 21 (6): 1989-1995.
342.White TJ, Santos MC, Thompson JS. Factors affecting wound complications in repair of ventral hernias. Am Surg 1998; 64 (3): 276-280.
343.Deysine M. Pathophysiology, prevention, and management of prosthetic infections in hernia surgery. Surg Clin North Am 1998; 78 (6): 1105-1115, viii.
344.Rios A, Rodriguez JM, Munitiz V et al. Antibiotic prophylaxis in incisional hernia repair using a prosthesis. Hernia 2001; 5 (3): 148-152.
345.Taylor EW, Byrne DJ, Leaper DJ et al. Antibiotic prophylaxis and open groin hernia repair. World J Surg 1997; 21 (8): 811-814; discussion 814-815.
346.Lazorthes F, Chiotasso P, Massip P et al. Local antibiotic prophylaxis in inguinal hernia repair. Surg Gynecol Obstet 1992; 175 (6): 569-570.
347.Musella M, Guido A, Musella S. Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg 2001;
167(2): 130-132.
348.Bandyk DF. Antibiotics-why so many and when should we use them? Semin Vasc Surg 2002; 15 (4): 268-274.
349.McQueen MM, Hughes SP, May P, Verity L. Cefuroxime in total joint arthroplasty. Intravenous or in bone cement. J Arthroplasty 1990; 5 (2): 169-172.
350.Murray WR. Use of antibiotic-containing bone cement. Clin Orthop Relat Res 1984; (190): 89-95.
285
351.Pratesi C, Russo D, Dorigo W, Chiti E. Antibiotic prophylaxis in clean surgery: vascular surgery. J Chemother 2001; 13 Spec No 1 (1): 123-128.
352.Gilbert AI, Felton LL. Infection in inguinal hernia repair considering biomaterials and antibiotics. Surg Gynecol Obstet 1993; 177 (2): 126-130.
353.Deysine M. Infections associated with surgical implants. N Engl J Med 2004; 351 (2): 193-195; author reply 193-195.
354.Badiou W, Lavigne JP, Bousquet PJ et al. In vitro and in vivo assessment of silvercoated polypropylene mesh to prevent infection in a rat model. Int Urogynecol J 2011; 22 (3): 265-272.
355.Dubay DA, Wang X, Kuhn MA et al. The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg 2004; 240 (1): 179-186.
356.Robson MC, Dubay DA, Wang X, Franz MG. Effect of cytokine growth factors on the prevention of acute wound failure. Wound Repair Regen 2004; 12 (1): 38-43.
357.Korenkov M, Yuecel N, Koebke J et al. Local administration of TGF-beta1 to reinforce the anterior abdominal wall in a rat model of incisional hernia. Hernia 2005; 9 (3): 252-258.
358.Orenstein SB, Saberski ER, Klueh U et al. Effects of mast cell modulation on early host response to implanted synthetic meshes. Hernia 2010; 14 (5): 511-516.
359.Tang L, Jennings TA, Eaton JW. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A 1998; 95 (15): 8841-8846.
360.Junge K, Klinge U, Rosch R et al. Improved collagen type I/III ratio at the interface of gentamicin-supplemented polyvinylidenfluoride mesh materials. Langenbecks Arch Surg 2007; 392 (4): 465-471.
361.Penttinen R, Gronroos JM. Mesh repair of common abdominal hernias: a review on experimental and clinical studies. Hernia 2008; 12 (4): 337-344.
362.Brockman JB, Patterson NW, Richardson WS. Burst strength of laparoscopic and open hernia repair. Surg Endosc 2004; 18 (3): 536-539.
286
363.Duffy AJ, Hogle NJ, LaPerle KM, Fowler DL. Comparison of two composite meshes using two fixation devices in a porcine laparoscopic ventral hernia repair model. Hernia 2004; 8 (4): 358-364.
364.Winslow ER, Diaz S, Desai K et al. Laparoscopic incisional hernia repair in a porcine model: what do transfixion sutures add? Surg Endosc 2004; 18 (3): 529-535.
365.Uen YH. Comparative laparoscopic evaluation of the PROLENE Polypropylene Hernia System vs. the PerFix Plug repair in a porcine groin hernia repair model. J Laparoendosc Adv Surg Tech A 2004; 14 (6): 368-373.
366.Silverman RP, Li EN, Holton LH, 3rd et al. Ventral hernia repair using allogenic acellular dermal matrix in a swine model. Hernia 2004; 8 (4): 336-342.
367.Brown SH, Banuelos K, Ward SR, Lieber RL. Architectural and morphological assessment of rat abdominal wall muscles: comparison for use as a human model. J Anat 2010; 217 (3): 196-202.
368.Konstantinovic ML, Pille E, Malinowska M et al. Tensile strength and host response towards different polypropylene implant materials used for augmentation of fascial repair in a rat model. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18 (6): 619-626.
369.DuBay DA, Choi W, Urbanchek MG et al. Incisional herniation induces decreased abdominal wall compliance via oblique muscle atrophy and fibrosis. Ann Surg 2007; 245 (1): 140-146.
370.DuBay DA, Wang X, Adamson B et al. Mesh incisional herniorrhaphy increases abdominal wall elastic properties: a mechanism for decreased hernia recurrences in comparison with suture repair. Surgery 2006; 140 (1): 14-24.
371.Demir U, Mihmanli M, Coskun H et al. Comparison of prosthetic materials in incisional hernia repair. Surg Today 2005; 35 (3): 223-227.
372.Junge K, Rosch R, Klinge U et al. Titanium coating of a polypropylene mesh for hernia repair: effect on biocompatibilty. Hernia 2005; 9 (2): 115-119.
373.Butler CE, Navarro FA, Orgill DP. Reduction of abdominal adhesions using composite collagen-GAG implants for ventral hernia repair. J Biomed Mater Res 2001; 58 (1): 75-80.
287
374.Butler CE, Prieto VG. Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction. Plast Reconstr Surg 2004; 114 (2): 464-473.
375.Gobin AS, Butler CE, Mathur AB. Repair and regeneration of the abdominal wall musculofascial defect using silk fibroin-chitosan blend. Tissue Eng 2006; 12 (12): 33833394.
376.Johnson EK, Hoyt CH, Dinsmore RC. Abdominal wall hernia repair: a long-term comparison of Sepramesh and Dualmesh in a rabbit hernia model. Am Surg 2004; 70 (8): 657-661.
377.Виноградов А.А., Плеханов А.Н., Товаршинов А.И. и соавт. Перспективы аллогерниопластики в лечении послеоперационных и рецидивных грыж Сибирский медицинский журнал 2009; 89 (6): 72-74.
378.Журавлев П.А., Строганов С.А. Оптимизация фиксирования сетчатого полипропиленового эксплантата при грыжепластике передней брюшной стенки способом sublay Анналы пластической, реконструктивной и эстетической хирургии
2011; (1): 68-72.
379. Загиров У.З., Салихов М.А., Исаев У.М. Анатомо-функциональное обоснование нового способа комбинированной пластики срединных вентральных грыж Хирургия. Журнал им. Н.И. Пирогова 2008; (7): 41-43.
380. Кошелев П.И., Глухов А.А., Мухтиар Хуссаин, Лейбович Б.Е.
Инновационные пути совершенствования методов ненатяжной герниопластики Системный анализ и управление в биомедицинских системах 2007; 6 (2): 528-532. 381. Куликов Л.К., Буслаев О.А., Шалашов С.В. и соавт. Хирургия послеоперационных грыж - новое решение Сибирский медицинский журнал (г.
Иркутск) 2011; 100 (1): 90-93.
382. Лядов В.К., Кубышкин В.А. Лапароскопическая интраперитонеальная пластика вентральных грыж: экспериментальные и клинические аспекты (обзор литературы) Анналы пластической, реконструктивной и эстетической хирургии
2008; (2): 90-98.
288
383. Меджидов Р.Т., Абдулмуслимов Х.М., Койчуев Р.А. Новый способ герниопластики при послеоперационных вентральных грыжах Научно-
медицинский вестник Центрального Черноземья 2007; (29): 147-149.
384. Паршиков В.В., Медведев А.П., Самсонов А.А. и соавт. Ненатяжная пластика в хирургии грыж брюшной стенки Вестник хирургии им. И.И. Грекова 2010; 169 (5):
74-79.
385. Паршиков В.В., Петров В.В., Ходак В.А. и соавт. Современные технологии в хирургии грыж передней брюшной стенки Современные технологии в медицине
2009; (1): 32-38.
386. Паршиков В.В., Романов Р.В., Градусов В.П. и соавт. Экспериментально-
клиническое обоснование применения эндопротезов из реперена для пластики брюшной стенки Вестник хирургии им. И.И. Грекова 2010; 169 (4): 26-30.
387. Протасов А.В., Смирнова Э.Д. Бесфиксационная герниопластика при грыжах передней брюшной стенки Вестник Российского университета дружбы народов.
Серия: Медицина 2011; (3): 42-45.
388.Eriksen JR, Gogenur I, Rosenberg J. Choice of mesh for laparoscopic ventral hernia repair. Hernia 2007; 11 (6): 481-492.
389.Coda A, Lamberti R, Martorana S. Classification of prosthetics used in hernia repair based on weight and biomaterial. Hernia 2012; 16 (1): 9-20.
390.Earle DB, Mark LA. Prosthetic material in inguinal hernia repair: how do I choose? Surg Clin North Am 2008; 88 (1): 179-201, x.
391.Hollinsky C, Sandberg S, Koch T, Seidler S. Biomechanical properties of lightweight versus heavyweight meshes for laparoscopic inguinal hernia repair and their impact on recurrence rates. Surg Endosc 2008; 22 (12): 2679-2685.
392.Kapischke M, Prinz K, Tepel J et al. Comparative investigation of alloplastic materials for hernia repair with improved methodology. Surg Endosc 2005; 19 (9): 12601265.
393.Schumpelick V, Conze J, Klinge U. [Preperitoneal mesh-plasty in incisional hernia repair. A comparative retrospective study of 272 operated incisional hernias]. Chirurg 1996; 67 (10): 1028-1035.
289
394.Bellon JM, Bajo A, Ga-Honduvilla N et al. Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg 2001; 233 (2): 287-291.
395.Klinge U, Si ZY, Zheng H et al. Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 2000; 32 (1): 43-48.
396.Klinge U, Zheng H, Si Z et al. Expression of the extracellular matrix proteins collagen I, collagen III and fibronectin and matrix metalloproteinase-1 and -13 in the skin of patients with inguinal hernia. Eur Surg Res 1999; 31 (6): 480-490.
397.Norman JN, Rahmat A, Smith G. Effect of supplements of zinc salts on the healing of incised wounds in the rat and guinea pig. J Nutr 1975; 105 (7): 822-826.
398.Agren MS. Studies on zinc in wound healing. Acta Derm Venereol Suppl (Stockh) 1990; 154 1-36.
399.Suomalainen K, Sorsa T, Ingman T et al. Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo. Oral Microbiol Immunol 1992; 7 (2): 121-123.
400.Lauhio A, Konttinen YT, Tschesche H et al. Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis. Antimicrob Agents Chemother 1994; 38 (2): 400-402.
401.Lee KS, Jin SM, Kim SS, Lee YC. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 2004; 113 (5): 902-909.
402.Lamparter S, Slight SH, Weber KT. Doxycycline and tissue repair in rats. J Lab Clin Med 2002; 139 (5): 295-302.
403.Vaxman F, Chalkiadakis G, Olender S et al. [Improvement in the healing of colonic anastomoses by vitamin B5 and C supplements. Experimental study in the rabbit]. Ann Chir 1990; 44 (7): 512-520.
404.Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg 2005; 31 (7 Pt 2): 814-817; discussion 818.
290